Graft Polymer (UK) PLC (GB:GPL) has released an update.
Graft Polymer (UK) PLC has bolstered its scientific leadership by appointing renowned neuroscience and public health authority Professor David Nutt as its Senior Scientific Adviser. Nutt, who is deeply involved in UK drug policy and mental health treatment research, brings a wealth of experience from his roles at Imperial College London and Awakn Life Sciences Corp. His expertise is expected to greatly contribute to Graft Polymer’s mission of pioneering innovative drug delivery solutions.
For further insights into GB:GPL stock, check out TipRanks’ Stock Analysis page.
